(l11)
OpenAs .pdf
See at PubMed
Randomization versus Real-World Evidence
Winterstein AG, Girman CJ, Pottegård A.
N Engl J Med. 2020 Jul 23;383(4):e21.

(l10)
OpenAs .pdf
See at PubMed
Author Response: Use of ß2-adrenoreceptor Agonist and Antagonist Drugs and Risk of Parkinson Disease
Pottegård A, Hopfner F, Wod M, Höglinger GU, Blaabjerg M, Rösler TW, Kuhlenbäumer G, Christensen K, Desuchl G.
Neurology. 2020 May 19;94(20):899.

(l9)
OpenAs .pdf
See at PubMed
Cohort selection in register-based studies of direct oral anticoagulant users with atrial fibrillation: An inevitable trade-off between selection bias and misclassification
Hellfritzsch M, Pottegård A, Haastrup SB, Rasmussen L, Grove EL.
Basic Clin Pharmacol Toxicol. 2020 May 4.

(l8)
OpenAs .pdf
See at PubMed
Comment on "Hydrochlorothiazide use and the risk of skin cancer in patients with hypertensive disorder: a nationwide retrospective cohort study from Korea"
Pottegård A, Morales D.
Korean J Intern Med. 2020 Mar 31.

(l7)
OpenAs .pdf
See at PubMed
Time for integrating clinical, lifestyle and molecular data to predict drug responses - Authors' reply.
Pottegård A, Friis S, Christensen RP, Habel LA, Gagne JJ, Hallas J.
EBioMedicine. 2016 May;7:11

(l6)
OpenAs .pdf
See at PubMed
Re: Pregabalin prescriptions in the United Kingdom - a drug utilisation study of The Health Improvement Network (THIN) primary care database by Asomaning et al.
Pottegård A, Tjäderborn M, Schjerning O, Nielsen J, Damkier P, Bodén R.
Int J Clin Pract. 2016 Aug;70(8):696

(l5)
OpenAs .pdf
See at PubMed
Inconsistencies in reporting of renal elimination among NOACs: the case of apixaban
Hellfritzsch M, Damkier P, Pottegård A, Grønlykke T, Grove EL.
Pharmacoepidemiol Drug Saf. 2016 Mar;25(3):346-8

(l4)
See at PubMed
Re: In utero SSRI exposure and risk of clubfoot
Henriksen DP, Pottegård A, Jimenez-Solem E, Damkier P.
Epidemiology. 2015 May;26(3):e34-5

(l3)
OpenAs .pdf
See at PubMed
Pregnancy and paracetamol: Methodological considerations on the study of associations between in utero exposure to drugs and childhood neurodevelopment
Damkier P, Pottegård A, Christensen RD, Hallas J.
Basic Clin Pharmacol Toxicol. 2015 Jan;116(1):2-5

(l2)
OpenAs .pdf
See at PubMed
Reply to "Evidence for harm, comment on..." by Kripke & Langer
Pottegård A, Friis S, Andersen M, Hallas J.
Br J Clin Pharmacol. 2014 Jul;78(1):188-9

(l1)
OpenAs .pdf
Hypnotics' association with mortality or cancer: bias related to the study design and analysis
Andersen M, Pottegård A, Friis S, Hallas J.


CONTACT INFORMATION

EMAIL ADDRESS
apottegaard@health.sdu.dk

PHONE NUMBER
+45 28913340


HOME ADDRESS
Anton Pottegaard
Lysalleen 7F
4000 Roskilde
DENMARK